Botwood Nicholas A.J.
Head of R&D, CMO · 6 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | Sale | 31,235 | $18.14 | $566,602.90 | filing |
| 2026-06-12 | SNDX | Syndax Pharmaceuticals Inc | Option exercise | 31,235 | $13.82 | $431,667.70 | filing |
| 2026-06-11 | SNDX | Syndax Pharmaceuticals Inc | Sale | 34,280 | $18.00 | $617,040.00 | filing |
| 2026-06-11 | SNDX | Syndax Pharmaceuticals Inc | Option exercise | 22,515 | $13.82 | $311,157.30 | filing |
| 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Award | 24,000 | $0.00 | $0.00 | filing |
| 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Award | 36,000 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.